Prot #GALACTIC-1: A Randomized, Double-blind, Multicentre, Parallel, Placebo-controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a

Project: Research project

Project Details

StatusActive
Effective start/end date7/23/207/23/23

Funding

  • INC Research, LLC (Prot #GALACTIC-1)
  • Galecto Biotech ApS (Prot #GALACTIC-1)